StockData
Pulmatrix, Inc. logo

Pulmatrix, Inc. (PULM) stock

PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.37+0.04 (+3.01%)

Close on Nov 17, 2026Market cap $5.00MP/E –Yield –

Pulmatrix r&d expenses

Research and development expenses are spending on new products and technology.

Pulmatrix's R&D Expenses for the twelve months ending Sep 30, 2025 was $47.00K, down 99.6% year over year. For fiscal 2025 it was $38.00K, down 99.5% from the year before. Over ten years it grew -40.8% a year on average. The highest annual figure on record is $18.24M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$38.00K-99.5%
FY2024Dec 31, 2024$7.17M-53.8%
FY2023Dec 31, 2023$15.52M-14.9%
FY2022Dec 31, 2022$18.24M+18.6%
FY2021Dec 31, 2021$15.38M-1.5%
FY2020Dec 31, 2020$15.61M+21.5%
FY2019Dec 31, 2019$12.85M-0.9%
FY2018Dec 31, 2018$12.97M+26.6%
FY2017Dec 31, 2017$10.24M+0.9%
FY2016Dec 31, 2016$10.15M+41.3%
FY2015Dec 31, 2015$7.19M+9.1%
FY2014Dec 31, 2014$6.59M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.00K-92.9%
Q2 FY2026Jun 30, 2026$2.00K-89.5%
Q1 FY2026Mar 31, 2026$3.00K-50.0%
Q3 FY2025Sep 30, 2025$8.00K-99.0%
Q2 FY2025Jun 30, 2025$14.00K-99.5%
Q1 FY2025Mar 31, 2025$19.00K-99.5%
Q4 FY2024Dec 31, 2024$6.00K-99.8%
Q3 FY2024Sep 30, 2024$814.00K-79.5%
Q2 FY2024Jun 30, 2024$2.83M-32.0%
Q1 FY2024Mar 31, 2024$3.51M-9.3%
Q4 FY2023Dec 31, 2023$3.52M-21.3%
Q3 FY2023Sep 30, 2023$3.96M-25.0%
Q2 FY2023Jun 30, 2023$4.17M-4.0%
Q1 FY2023Mar 31, 2023$3.87M-6.6%
Q4 FY2022Dec 31, 2022$4.47M+51.0%
Q3 FY2022Sep 30, 2022$5.29M+31.3%
Q2 FY2022Jun 30, 2022$4.34M-4.5%
Q1 FY2022Mar 31, 2022$4.15M+7.6%
Q4 FY2021Dec 31, 2021$2.96M-9.4%
Q3 FY2021Sep 30, 2021$4.03M+4.0%
Q2 FY2021Jun 30, 2021$4.54M+42.6%
Q1 FY2021Mar 31, 2021$3.86M-27.1%
Q4 FY2020Dec 31, 2020$3.27M-22.4%
Q3 FY2020Sep 30, 2020$3.87M+17.5%
Q2 FY2020Jun 30, 2020$3.18M+0.6%
Q1 FY2020Mar 31, 2020$5.29M+143.0%
Q4 FY2019Dec 31, 2019$4.21M+30.6%
Q3 FY2019Sep 30, 2019$3.30M+7.9%
Q2 FY2019Jun 30, 2019$3.16M-21.2%
Q1 FY2019Mar 31, 2019$2.18M-32.4%
Q4 FY2018Dec 31, 2018$3.22M+24.4%
Q3 FY2018Sep 30, 2018$3.06M+16.7%
Q2 FY2018Jun 30, 2018$4.01M+19.3%
Q1 FY2018Mar 31, 2018$3.22M+92.6%
Q4 FY2017Dec 31, 2017$2.59M-6.7%
Q3 FY2017Sep 30, 2017$2.62M–
Q2 FY2017Jun 30, 2017$3.36M–
Q1 FY2017Mar 31, 2017$1.67M–
Q4 FY2016Dec 31, 2016$2.77M–

More Pulmatrix figures

See a number that looks wrong?